Aurinia Pharmaceuticals Inc (AUPH)
EBITDA Margin
60.42%
TTM · Period ending:
AUPH EBITDA Margin
Latest reported60.42%period ending
Latest reported60.42%period ending
AUPH TTM EBITDA Margin (-75.27% → 60.42%)
TTM ebitda margin
High-resolution chart · PNG
AUPH ebitda margin history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Margin |
|---|---|
| -737.2419% | |
| -713.738% | |
| -401.5403% | |
| -282.196% | |
| -133.308% | |
| -75.2695% |